In Vitro Pharmacokinetic/Pharmacodynamic Modelling and Simulation of Amphotericin B against <i>Candida auris</i>

The aims of this study were to characterize the antifungal activity of amphotericin B against <i>Candida auris</i> in a static in vitro system and to evaluate different dosing schedules and MIC scenarios by means of semi-mechanistic pharmacokinetic/pharmacodynamic (PK/PD) modelling and s...

Full description

Bibliographic Details
Published in:	Pharmaceutics
Main Authors:	Unai Caballero, Elena Eraso, Javier Pemán, Guillermo Quindós, Valvanera Vozmediano, Stephan Schmidt, Nerea Jauregizar
Format:	Article
Language:	English
Published:	MDPI AG 2021-10-01
Subjects:	<i>Candida auris</i> PK/PD model amphotericin B time-kill curves
Online Access:	https://www.mdpi.com/1999-4923/13/11/1767

Similar Items

In Vitro Interaction and Killing-Kinetics of Amphotericin B Combined with Anidulafungin or Caspofungin against <i>Candida auris</i>
by: Unai Caballero, et al.
Published: (2021-08-01)

Unpredictable In Vitro Killing Activity of Amphotericin B against Four <i>Candida auris</i> Clades
by: Zoltán Papp, et al.
Published: (2021-08-01)

In Vitro Synergistic Interactions of Isavuconazole and Echinocandins against <i>Candida auris</i>
by: Unai Caballero, et al.
Published: (2021-03-01)

In Vitro and In Vivo Activity of Citral in Combination with Amphotericin B, Anidulafungin and Fluconazole against <i>Candida auris</i> Isolates
by: Iñigo de-la-Fuente, et al.
Published: (2023-06-01)

Efficacy of the combination of amphotericin B and echinocandins against Candida auris in vitro and in the Caenorhabditis elegans host model
by: Ainara Hernando-Ortiz, et al.
Published: (2024-01-01)

In Vivo Efficacy of Amphotericin B against Four <i>Candida auris</i> Clades
by: Lajos Forgács, et al.
Published: (2022-05-01)

Nanoemulsion Increases the Antifungal Activity of Amphotericin B against Four <i>Candida auris</i> Clades: In Vitro and In Vivo Assays
by: Gabriel Davi Marena, et al.
Published: (2023-06-01)

The Micronaut–AM antifungal susceptibility testing method does not overestimate amphotericin B resistance in Candida auris
by: Paraskevi Mantzana, et al.
Published: (2024-05-01)

Successful Treatment of Refractory Candida auris Ventriculitis With Intraventricular Liposomal Amphotericin B
by: Christine A. Vu, et al.
Published: (2025-09-01)

Antifungal Resistance in <i>Candida auris</i>: Molecular Determinants
by: María Guadalupe Frías-De-León, et al.
Published: (2020-09-01)

Comparison of In Vitro Killing Activity of Rezafungin, Anidulafungin, Caspofungin, and Micafungin against Four <i>Candida auris</i> Clades in RPMI-1640 in the Absence and Presence of Human Serum
by: Renátó Kovács, et al.
Published: (2021-04-01)

PK/PD modeling and simulation of the in vitro activity of the combinations of isavuconazole with echinocandins against Candida auris
by: Unai Caballero, et al.
Published: (2023-06-01)

Letter to the editor: lansoprazole interferes with fungal respiration and acts synergistically with amphotericin B against multidrug-resistant Candida auris
by: Meng Zhu, et al.
Published: (2024-12-01)

NO <i>Candida auris</i>: Nitric Oxide in Nanotherapeutics to Combat Emerging Fungal Pathogen <i>Candida auris</i>
by: Levi G. Cleare, et al.
Published: (2020-06-01)

Successful treatment of a Candida auris intra-articular infection
by: Scott C. Roberts, et al.
Published: (2019-01-01)

<i>Candida auris</i>: An Overview of How to Screen, Detect, Test and Control This Emerging Pathogen
by: Teresa Fasciana, et al.
Published: (2020-11-01)

In Vitro Assessment of Fluconazole and Cyclosporine A Antifungal Activities: A Promising Drug Combination Against Different <i>Candida</i> Species
by: Juan Daniel Carton, et al.
Published: (2025-02-01)

Vacuolar Proteases of <i>Candida auris</i> from Clades III and IV and Their Relationship with Autophagy
by: Daniel Clark-Flores, et al.
Published: (2025-05-01)

Diagnostic Allele-Specific PCR for the Identification of <i>Candida auris</i> Clades
by: Hans Carolus, et al.
Published: (2021-09-01)

Virulence Traits and Azole Resistance in Korean <i>Candida auris</i> Isolates
by: Seung A. Byun, et al.
Published: (2023-09-01)

Potential Activity of Micafungin and Amphotericin B Co-Encapsulated in Nanoemulsion against Systemic <i>Candida auris</i> Infection in a Mice Model
by: Gabriel Davi Marena, et al.
Published: (2024-03-01)

International Multicentre Study of <i>Candida auris</i> Infections
by: Nirav Pandya, et al.
Published: (2021-10-01)

What Do We Know about <i>Candida auris</i>? State of the Art, Knowledge Gaps, and Future Directions
by: Victor Garcia-Bustos, et al.
Published: (2021-10-01)

<i>Candida auris</i>: A Continuing Threat
by: Ashish Bhargava, et al.
Published: (2025-03-01)

Novel Chromogenic Medium CHROMagar<sup>TM</sup> Candida Plus for Detection of <i>Candida auris</i> and Other <i>Candida</i> Species from Surveillance and Environmental Samples: A Multicenter Study
by: Juan Vicente Mulet Bayona, et al.
Published: (2022-03-01)

The First Two Cases of <i>Candida</i> <i>auris</i> in The Netherlands
by: Erik H. Vogelzang, et al.
Published: (2019-09-01)

Patterns and Predictors of <i>Candida auris</i> Candidemia with Multidrug-Resistant Bacterial Co-Infections: Results from the CANDI-MDR Study
by: Karolina Akinosoglou, et al.
Published: (2025-05-01)

Echinocandins as Biotechnological Tools for Treating <i>Candida auris</i> Infections
by: Elizabete de Souza Cândido, et al.
Published: (2020-09-01)

Pathogenesis, Prophylaxis, and Treatment of <i>Candida auris</i>
by: Madalina Preda, et al.
Published: (2024-03-01)

Changing Epidemiology of <i>Candida</i> spp. Causing Bloodstream Infections in a Tertiary Hospital in Northern Greece: Appearance of <i>Candida auris</i>
by: Athina Pyrpasopoulou, et al.
Published: (2025-02-01)

<i>Candida auris</i>: A Mini Review on Epidemiology in Healthcare Facilities in Asia
by: Nishanthinie Thatchanamoorthy, et al.
Published: (2022-10-01)

Nanotechnology-Based Strategies to Combat Multidrug-Resistant <i>Candida auris</i> Infections
by: Helal F. Hetta, et al.
Published: (2023-08-01)

Overestimation of Amphotericin B Resistance in Candida auris with Sensititre YeastOne Antifungal Susceptibility Testing: a Need for Adjustment for Correct Interpretation
by: Maria Siopi, et al.
Published: (2023-06-01)

Melanization of <i>Candida auris</i> Is Associated with Alteration of Extracellular pH
by: Daniel F. Q. Smith, et al.
Published: (2022-10-01)

Ibrexafungerp: A Novel Oral Triterpenoid Antifungal in Development for the Treatment of <i>Candida auris</i> Infections
by: Mahmoud Ghannoum, et al.
Published: (2020-08-01)

<i>Candida auris</i> — a New Pathogen of Nosocomial Infections
by: T. V. Chernenkaya
Published: (2024-09-01)

An Overview on <i>Candida auris</i> in Healthcare Settings
by: Maria Luisa Cristina, et al.
Published: (2023-09-01)

Essential Oils against <i>Candida auris</i>—A Promising Approach for Antifungal Activity
by: Adam Kowalczyk
Published: (2024-06-01)

The Mortality Attributable to Candidemia in <i>C. auris</i> Is Higher than That in Other <i>Candida</i> Species: Myth or Reality?
by: Carlos A. Alvarez-Moreno, et al.
Published: (2023-03-01)

Sunflower Oil and Cholesterol Nanoemulsion: A Novel Carrier for Micafungin to Combat Multi-Resistant <i>Candida auris</i>
by: Gabriel Davi Marena, et al.
Published: (2024-06-01)